SLC17A3, also known as the Solute Carrier Family 17 Member 3, plays a pivotal role in the body's physiological transport processes. Functioning as a transporter for organic anions, this protein facilitates the movement of specific molecules across cellular membranes, which is crucial for maintaining cellular homeostasis and metabolic function. The gene encoding SLC17A3 is predominantly expressed in the liver, where it is involved in the excretion and reabsorption of metabolites and xenobiotics, substances foreign to the body's natural biochemical environment. The regulation of SLC17A3 expression is a complex interplay between various cellular signals and transcription factors, which collectively ensure that the protein's levels are maintained within a range that is congruent with the body's metabolic demands.
A variety of chemical compounds have been identified that can potentially serve as activators for the expression of SLC17A3, each operating through distinct molecular mechanisms. Retinoic acid, for example, is known to interact with nuclear receptors to initiate the transcription of genes, including those related to anion transport. Similarly, vitamin D, through its active form 1,25-dihydroxyvitamin D3, can bind to its specific receptor, potentially enhancing the expression of genes involved in phosphate transport. Forskolin, by increasing intracellular cyclic AMP (cAMP), activates cAMP response element-binding protein (CREB), which may lead to the initiation of transcription for a variety of genes. Other compounds like the histone deacetylase inhibitors Trichostatin A and Sodium Butyrate can alter the chromatin structure to a state more conducive for transcription, thereby potentially increasing the expression of SLC17A3. These compounds, along with others like Lithium Chloride and Curcumin, demonstrate the diversity of molecules that can signal the upregulation of SLC17A3, highlighting the intricate network of regulatory mechanisms that govern gene expression.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid may upregulate SLC17A3 by binding to retinoic acid receptors, which can initiate transcription of genes involved in organic anion transport. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
This form of vitamin D can stimulate SLC17A3 transcription by interacting with the vitamin D receptor, enhancing the expression of genes linked to phosphate transport. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin may increase SLC17A3 expression through elevating intracellular cAMP levels, subsequently activating the cAMP response element-binding (CREB) pathway, which can initiate transcription of a wide array of genes. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol could upregulate SLC17A3 expression by binding to estrogen receptors, which may stimulate the transcription of genes associated with anion transport and metabolism. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, Trichostatin A could promote the upregulation of SLC17A3 by altering chromatin structure, thereby facilitating transcriptional activation of genes. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may induce SLC17A3 expression by causing DNA demethylation, which can lead to the activation of gene transcription that is otherwise suppressed by methylation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate can stimulate the transcription of SLC17A3 by inhibiting histone deacetylases, leading to an open chromatin conformation and increased gene expression. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
Docosahexaenoic acid (DHA), an omega-3 fatty acid, may upregulate SLC17A3 by incorporating into cell membranes and altering signaling pathways that govern gene transcription. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can increase SLC17A3 expression potentially through the inhibition of glycogen synthase kinase 3 (GSK-3), which may lead to enhanced transcriptional activity of genes related to ionic homeostasis. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin may induce the expression of SLC17A3 through its role as a modulator of transcription factors, such as NF-κB, which can stimulate the transcription of a variety of genes, including those involved in anion transport. | ||||||